Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFDA Approves Besivance to Treat Bacterial Conjunctivitis
FDA Press Releases , 05/29/09
The U.S. Food and Drug Administration today approved Besivance for the treatment of bacterial conjunctivitis, a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes. "Bacterial conjunctivitis is a common condition that affects people of all ages," said Wiley A. Chambers, M.D., acting director of the Division of Anti-Infective and Ophthalmology Products in FDA's Center for Drug Evaluation and Research. "It is important to have a variety of treatment options available to health care professionals and patients because an effective drug therapy can reduce the duration of the illness and reduce the chances of infecting others."
Related Articles
Successful treatment of ligneous conjunctivitis with topical cyclosporine and heparin
Journal of American Association for Pediatric Ophthalmology and Strabismus, 11/03/09
Relevance Score: 88%
Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing
Canadian Family Physician, 11/13/09
Relevance Score: 87%
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Relevance Score: 85%
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children
Clinical Therapeutics, 10/29/09
Relevance Score: 85%
Relationship between myopia and allergen-specific serum IgE levels in patients with allergic conjunctivitis
Clinical and Experimental Ophthalmology, 10/09/09
Relevance Score: 84%
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor